Allspring Global Investments’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Sell
15,357
-14,581
-49% -$1.03M ﹤0.01% 1178
2025
Q4
$2.1M Buy
29,938
+1,821
+6% +$122K ﹤0.01% 1017
2025
Q3
$2.11M Buy
28,117
+20,033
+248% +$1.33M ﹤0.01% 1016
2025
Q2
$428K Sell
8,084
-32,833
-80% -$1.87M ﹤0.01% 1390
2025
Q1
$2.53M Sell
40,917
-5,610
-12% -$326K ﹤0.01% 1053
2024
Q4
$2.23M Sell
46,527
-556,772
-92% -$28.5M ﹤0.01% 1122
2024
Q3
$34.5M Sell
603,299
-79,548
-12% -$4.56M 0.05% 410
2024
Q2
$35.8M Sell
682,847
-13,280
-2% -$582K 0.06% 384
2024
Q1
$28.3M Sell
696,127
-31,871
-4% -$1.19M 0.04% 478
2023
Q4
$26.9M Sell
727,998
-159,276
-18% -$6M 0.04% 482
2023
Q3
$33.9M Buy
887,274
+563,989
+174% +$23.1M 0.06% 403
2023
Q2
$11.7M Buy
323,285
+80,582
+33% +$2.75M 0.02% 747
2023
Q1
$9.27M Sell
242,703
-155,513
-39% -$7.29M 0.02% 799
2022
Q4
$22.7M Sell
398,216
-345,471
-46% -$17.7M 0.04% 546
2022
Q3
$29.4M Buy
743,687
+117,645
+19% +$5.2M 0.05% 459
2022
Q2
$27.5M Sell
626,042
-72,862
-10% -$3.15M 0.05% 494
2022
Q1
$27.9M Sell
698,904
-191,033
-21% -$6.8M 0.04% 561
2021
Q4
$35.8M Buy
+889,937
New +$33.2M 0.04% 535

Other funds holding HALO

Allspring Global Investments's HALO Position: Q1 2026 in Review

Allspring Global Investments reduced its Halozyme (HALO) stake by 49% in Q1 2026, selling an estimated $1.03M and leaving 15,357 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

Allspring Global Investments first reported a position in HALO in Q4 2021 and has held it in 18 quarters since. The position peaked at $35.8M in Q4 2021. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Allspring Global Investments held 15,357 shares of Halozyme worth $1M as of Q1 2026.
  • Allspring Global Investments sold 14,581 Halozyme shares in Q1 2026, an estimated $1.03M.
  • Halozyme made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1178 holding.
  • Allspring Global Investments first reported a position in Halozyme in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Halozyme position peaked at $35.8M in Q4 2021.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.